These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16848812

  • 1. Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution.
    Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Di Marco R, Malaguarnera M.
    Am J Gastroenterol; 2006 Sep; 101(9):2060-9. PubMed ID: 16848812
    [Abstract] [Full Text] [Related]

  • 2. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease.
    Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Nicoletti F, Malaguarnera M.
    Gut; 2006 Sep; 55(9):1313-20. PubMed ID: 16825325
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL.
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [Abstract] [Full Text] [Related]

  • 9. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C.
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G, Erdem O, Yilmaz G.
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis.
    Alaaeddine N, Sidaoui J, Hilal G, Serhal R, Abedelrahman A, Khoury S.
    Eur Cytokine Netw; 2012 Dec; 23(3):107-11. PubMed ID: 23009757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.